-
No difference in heart outcomes found in use of two diuretics to treat blood pressure
[ad_1] Research Highlights: In a study comparing the effectiveness of two high blood pressure medications (both diuretics) among elderly veterans,…
Read More » -
Novel gene-editing therapy shows promise for patients with transthyretin amyloid cardiomyopathy
[ad_1] Research Highlights: In a clinical trial, a single intravenous infusion of NTLA-2001, a novel gene-editing therapy based on CRISPR/Cas9,…
Read More » -
Intravenous iron improved long-term outcomes for people with heart failure and iron deficiency
[ad_1] Research Highlights: Repeated intravenous (IV) administration of iron reduced the risk of hospitalization for heart failure and cardiovascular death…
Read More » -
New medicine reduces triglyceride by 25%, no change in CVD risk in people with Type 2 diabetes
[ad_1] Research Highlights: A new cholesterol medication, pemafibrate, lowered triglyceride levels among adults with Type 2 diabetes, however, there was…
Read More » -
Todos Medical Announces BioFuture NYC 2022 Presentation
[ad_1] New York, NY, and Tel Aviv, ISRAEL – (NewMediaWire) – November 4, 2022 – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive…
Read More »